back to news︁

Prellis is a pioneer in the construction of human cells, organoids and organoid systems based on proprietary biologics workflows. Prellis has developed the EXIS antibody discovery platform which can be used to generate antibody libraries with novel, target-specific drug candidates. The EXIS platform mimics the natural human immune process in vitro, representing the gold standard in drug discovery.

Prellis Biologics raises $14.5M, debuts a ‘human immune system’ in a dish

Related News

December 15, 2021

Prellis Biologics raises $14.5M, debuts a ‘human immune system’ in a dish

back to news︁

Prellis Biologics raises $14.5M, debuts a ‘human immune system’ in a dish

Prellis Biologics raises $14.5M, debuts a ‘human immune system’ in a dish

Related News